| Bioactivity | PROTAC CDK9 degrader-9 (compound 29) is a highly selective and efficient CDK9 degrader based on PROTAC technology. PROTAC CDK9 degrader-9 can be used in anti-cancer research[1]. |
| Formula | C42H51FN12O6 |
| Molar Mass | 838.93 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Nie HJ,et al. Discovery of a Potent, selective and orally bioavailable CDK9 degrader for targeting transcription regulation in Triple-Negative breast cancer. Bioorg Chem. 2024 Oct 9;153:107876. |
PROTAC CDK9 degrader-9
CAS: F: C42H51FN12O6 W: 838.93
PROTAC CDK9 degrader-9 (compound 29) is a highly selective and efficient CDK9 degrader based on PROTAC technology. PROTA
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.